CLGM
ELV icon

Capitolis Liquid Global Markets’s Elevance Health ELV Stock Holding History

Capitolis Liquid Global Markets’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19M Sell
65,038
-9,962
-13% -$3.27M 0.12% 134
2025
Q4 		$26.3M Buy
75,000
+37,000
+97% +$12.5M 0.16% 100
2025
Q3 		$12.3M Hold
38,000
– – 0.1% 125
2025
Q2 		$14.8M Sell
38,000
-7,000
-16% -$2.82M 0.11% 124
2025
Q1 		$19.6M Hold
45,000
– – 0.17% 85
2024
Q4 		$16.6M Buy
+45,000
New +$18.8M 0.16% 68

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Capitolis Liquid Global Markets's ELV Position: Q1 2026 in Review

Capitolis Liquid Global Markets reduced its Elevance Health (ELV) stake by 13% in Q1 2026, selling an estimated $3.27M and leaving 65,038 shares worth $19M. The position accounts for 0.12% of the portfolio, ranked #134.

Capitolis Liquid Global Markets first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $26.3M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Capitolis Liquid Global Markets held 65,038 shares of Elevance Health worth $19M as of Q1 2026.
  • Capitolis Liquid Global Markets sold 9,962 Elevance Health shares in Q1 2026, an estimated $3.27M.
  • Elevance Health made up 0.12% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #134 holding.
  • Capitolis Liquid Global Markets first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Capitolis Liquid Global Markets's Elevance Health position peaked at $26.3M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.